Back to mobile site

More on SABS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.3 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SAB Biotherapeutics (NQ:SABS)
Delayed: 3.50 +0.11 (3.24%)
Prev. Close $3.39  
Open$3.43 
52 Wk High$ 
52 Wk Low$ 
Day High$3.52 
Day Low$3.42 
P/E N/A  
EPS$ 
Volume374,471 

Friends, Peers and Foes (?): SABSW EBS (more...)

Aug 21, 2026 04:30 PM Form 424B3 SAB Biotherapeutics,
Aug 14, 2026 05:24 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC
Aug 14, 2026 04:53 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Caligan Partners LP
Aug 14, 2026 04:14 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Commodore Capital LP
Aug 14, 2026 04:13 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Aug 14, 2026 11:04 AM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Woodline Partners LP
Aug 14, 2026 06:14 AM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 12, 2026 12:09 PM Form SCHEDULE 13G SAB Biotherapeutics, Filed by: Adage Capital Management, L.P.
Aug 10, 2026 04:27 PM Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 6, 2026 07:57 AM Form 10-Q SAB Biotherapeutics, For: Jun 30
View All Articles

Entities mentioned with SABS

View All Entities